Rigel Pharmaceuticals, Inc. (RIGL)
45.16
-0.72
(-1.58%)
USD |
NASDAQ |
Aug 24, 16:00
45.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals EPS Diluted (Quarterly) : 0.8835 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8835 |
| March 31, 2026 | 0.4396 |
| December 31, 2025 | 13.54 |
| September 30, 2025 | 1.456 |
| June 30, 2025 | 3.282 |
| March 31, 2025 | 0.63 |
| December 31, 2024 | 0.7973 |
| September 30, 2024 | 0.7038 |
| June 30, 2024 | -0.0587 |
| March 31, 2024 | -0.4707 |
| December 31, 2023 | 0.0422 |
| September 30, 2023 | -0.3264 |
| June 30, 2023 | -0.3799 |
| March 31, 2023 | -0.7799 |
| December 31, 2022 | 0.0811 |
| September 30, 2022 | -1.101 |
| June 30, 2022 | -0.7837 |
| March 31, 2022 | -1.598 |
| December 31, 2021 | -1.324 |
| September 30, 2021 | -1.226 |
| June 30, 2021 | -0.8121 |
| March 31, 2021 | 2.243 |
| December 31, 2020 | -1.138 |
| September 30, 2020 | -0.839 |
| June 30, 2020 | -1.043 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.260 |
| December 31, 2019 | -1.026 |
| September 30, 2019 | -0.6855 |
| June 30, 2019 | -1.232 |
| March 31, 2019 | -1.053 |
| December 31, 2018 | 0.1926 |
| September 30, 2018 | -1.428 |
| June 30, 2018 | -1.60 |
| March 31, 2018 | -1.70 |
| December 31, 2017 | -1.80 |
| September 30, 2017 | -1.40 |
| June 30, 2017 | -1.60 |
| March 31, 2017 | -1.30 |
| December 31, 2016 | -1.60 |
| September 30, 2016 | -2.40 |
| June 30, 2016 | -1.50 |
| March 31, 2016 | -1.90 |
| December 31, 2015 | -1.40 |
| September 30, 2015 | -0.80 |
| June 30, 2015 | -1.60 |
| March 31, 2015 | -2.10 |
| December 31, 2014 | -2.50 |
| September 30, 2014 | -2.40 |
| June 30, 2014 | -2.90 |
| March 31, 2014 | -2.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.3068 |
| Cytokinetics, Inc. | -1.505 |
| Perspective Therapeutics, Inc. | -0.222 |
| Capricor Therapeutics, Inc. | -0.7032 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.29M |
| Revenue (Quarterly) | 78.70M |
| Total Expenses (Quarterly) | 61.41M |
| Enterprise Value | 800.65M |
| Gross Profit Margin (Quarterly) | 89.17% |
| Profit Margin (Quarterly) | 21.97% |
| Earnings Yield | 36.14% |
| Operating Earnings Yield | 9.86% |
| Normalized Earnings Yield | 36.16 |